Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.
What annoy s me most is that on the face of it this asset should sell itself. I was cautious about buying in as I did a bit of research but didnt sell out most of my stock until it was too late. Im going to wait before getting back in but I really want a proper management update and detailed plan of action before that
That has nt changed, at least we have a minimum cons estimate of value. Question is, is there interest..should be. Its a safe juristriction with existing mines that needs jobs and resource is in demand. It would be nice to see more of lr now this is out. £2m mc is pitifull given the npv.
Thanks for clarifying mani, was going to send a email myself if no one else had. I think we should just ignore cb and zen as they are clearly incapable of having a rational discussion. We must be nearing the yoda results which will be interesting. Im hoping that trauma kine can still be commercially viable and give a material boost in the short term whilst clevegen moves forward.
For the record im not mani and 1000 posts repeating rns extracts or cherry picking dont make for an good discussion. Im actually positive about this share even when it dropped from 120p. I believe we will get a partner and Faron probably have one lined up however the line 'the, a' is not exactly proof a partnership is in place. A rns is needed for that.
Its one thing being positive, its another to completely disregard a reasonable view. Of course the share price will depend on the terms of a deal, just suggest it wouldn't zengagh is clearly ridiculous. Wharever you say clearly there is a limit to Farons funding. They need a partner and a pharma company knows this.
This board was quite good 6months ago but seems to have fallen into you and cb bashing anyone who is more balanced or takes a different view. Im still hopeful in the short term that yoda provides a clear indication that traumakine is commercial and we get uplift from that but the drugs market appears to be smaller than was consider when sp was £8. Still great potential from 60p. Im happy we seem to have some base support now at this level rather than the 55p last month. Clevegen drip feed should help until and deal is announced ive had personal experience of a scare re c.r.c and im excited about the future but realistic given the difficulties of getting Pharma to market. Nice to see a rise this am. Gla
Cb1984 just keep living in your fantasy world with zengagh. I hope your both right. Faron do not have endless supply of cash, this puts them in a weaker position. Hopefully yoda can prove traumakine is a viable commercial drug and imho this is what ceo is waiting for before any deal will be confirmed.
Totally disagree with you guys about mani, she is clearly just taking a more balanced view than you guys. Given the history of this share I say having concerns is only natural and reasonable. I hope your all right though I am invested here too and want this to turn around. Stop bashing anyone who has a different view, politely disagree with reasoned points.
I just wish I had more to invest but I dont so this will be held. Given the european commission interest and the significant unmet demand the route to market is there and as soon as the other trials confirm the latest revelations I think they will fast track production. Im happy to wait. To be honest the real winners here will be ards patients so even more invcentive for this to get done, but properly. GLA
Delighted with this news but as a relatively new investor what do folk think are the chances of a div? Clearly reinvestment is important given the reserves but a div would surley be a great way to further grow the sp but given interests how likely is this in the short term? Any thoughts
Im not really qualified to add investing advice as this is my first ever investment and I have a relatively small amount of shares. I bought in at 60p as after researching the company and why sp had dropped I figured this was a overreaction as clevegen still clearly had value even if traumakine was a failure. If you look at the way this moves its obvious that pi shares are being eaten up. Whilst I could have made money selling on highs my concern was always buying back in. With so many locked in after purchasing at high prices all we need is for pi not to take the bait to sell and this will motor short term. Imo the jap results will confirm tang benefits for certain patients with ards. Whilst value may not be as high as if the drug was successful across all groups what Faron needs is a secure revenue shorter term. In this for long term, who knows maybe even a retirement plan! Good luck everyone and hopefully those invested at £8 will see money back